GlassScriptPhysician profile
Benjamin Y Xu
NPI 1487910063
$21,548.14
in general payments reported to CMS, 2019-2025
20 companies · $1,485 in 2025
The $1,485 reported for 2025 was more than what 85% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,163 · 2020: $578 · 2021: $3,550 · 2022: $6,998 · 2023: $5,106 · 2024: $2,668 · 2025: $1,485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,509 · Consulting Fee: $4,181 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Travel and Lodging: $68.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,509.07 |
| Consulting Fee | $4,181.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Travel and Lodging | $68.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $9,829.87 | 2021-2025 | Xen Glaucoma Treatment System, Ozurdex |
| Alcon Research LLC | $2,918.75 | 2023-2024 | |
| Allergan, INC. | $2,148.43 | 2019-2022 | |
| Heidelberg Engineering, INC. | $1,845.50 | 2019-2024 | Spectralis |
| Alcon Vision LLC | $1,776.14 | 2019-2025 | Hydrus Microstent, Clareon |
| Glaukos Corporation | $572.70 | 2019-2025 | Idosetr, Istent Infinite, Iaccess Precision Blade |
| Sight Sciences, INC. | $424.17 | 2021-2023 | Omni Surgical System |
| New World Medical,INC. | $423.22 | 2019-2025 | Streamline, Kahook Dual Blade, Clearpath |
| Johnson & Johnson Surgical Vision, INC. | $301.57 | 2022-2025 | Amo Phaco Needle, Tecnis Simplicity |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $271.87 | 2019-2021 | |
| Boston Scientific Corporation | $259.34 | 2022-2024 | Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd |
| Ivantis, INC | $154.08 | 2020 | |
| Nova Eye, INC. | $135.57 | 2025 | |
| Carl Zeiss Meditec, INC. | $123.68 | 2023 | Plex Elite |
| Regeneron Pharmaceuticals, INC. | $107.41 | 2023 | Eylea |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Topcon Healthcare, INC. | $91.16 | 2023 | |
| Bausch & Lomb Americas INC. | $84.22 | 2023 | Envista Mx60 Iol, Amvisc |
| Dompe US, INC. | $36.04 | 2022 | |
| Ocular Therapeutix, INC. | $30.84 | 2022 | |
| Stryker Corporation | $13.58 | 2023 | Vsp System, Vsp Cranial, Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Xu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.